Abstract

Introduction and Aim: A recent European Liver Transplant registry study showed that the proportion of liver transplants performed for nonalcoholic steatohepatitis (NASH) in Europe has increased from 2002 through 2016, and that the post-transplant outcome in patients with NASH is comparable to that of other disease indications. There are few data on recent trends in waiting list inscriptions/dynamics, and on intention-to-treat transplant survival of NASH patients, however.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call